Antidote to new oral anticoagulants proves effective Anticoagulant effects of factor Xa inhibitors can be reversed by inactive recombinant factor Xa protein, andexanet, study shows.…
Anti-cholesterol vaccine shows promise A vaccine that targets PCSK9 could be a cost effective approach to lowering cholesterol.…
FDA approves Factor X therapy for rare bleeding condition The US Food and Drug Administration has approved a purified clotting factor for patients with hereditary Factor X deficiency.…
FDA approves idarucizumab as antidote to dabigatran The US medicines safety watchdog has given fast-track approval to idarucizumab (Praxbind), a drug that can neutralise the effects of the anticoagulant dabigatran etexilate (Pradaxa).…
Anticoagulant antidote idarucizumab gets European regulator’s initial approval Idarucizumab (Praxbind), a unique drug that can neutralise the effect of anticoagulant dabigatran etexilate (Pradaxa), has been recommended for marketing authorisation by the European medicines safety watchdog.…
UK launch for cholesterol-lowering PCSK9 inhibitor An injectable treatment has been launched for people who struggle to control their cholesterol levels through established diet and drug regimes, including patients with the genetic lipid disorder familial hypercholesterolaemia.…
Scientists get closer to finding out why statins cause muscle pain Chemical conversion of statins could disrupt muscle mitochondria function, leading to pain and weakness.…
Under treatment of venous thromboembolism persists in cardiac unit Researchers introduced a new protocol in a cardiology unit to help ensure patients at risk were put on anticoagulants, but there were still high rates of under treatment.…
Metformin plays a role in lowering blood cholesterol Metformin, one of the most widely used medications for type 2 diabetes, has a positive effect on LDL cholesterol as well as blood glucose, according to research published in Diabetes Care.…
Rapid uptake of new oral anticoagulants in the United States More patients with atrial fibrillation are being protected against blood clots after the introduction of new direct oral anticoagulant drugs.…